Nyemba Mbekeani
About Nyemba Mbekeani
Nyemba Mbekeani is the Director and GPS Business Intelligence Integration Lead at Bristol Myers Squibb, with extensive experience in biopharma operations and quality management.
Company: Bristol Myers Squibb
Currently, Nyemba Mbekeani is the Director, GPS Business Intelligence Integration Lead at Bristol Myers Squibb. In this strategic role, he oversees the integration of business intelligence within the Global Product Supply (GPS) team, spearheading efforts to optimize operations and enhance data-driven decision-making processes.
Title: Director, GPS Business Intelligence Integration Lead
Nyemba Mbekeani holds the position of Director, GPS Business Intelligence Integration Lead at Bristol Myers Squibb. His responsibilities include leading the integration of business intelligence tools and strategies within the GPS team, working to improve operational efficiencies and provide insights that drive business decisions.
Title: Associate Director, Vendor Quality Management
Before his current role, Nyemba Mbekeani served as Associate Director, Vendor Quality Management at Vertex Pharmaceuticals from 2022 to 2024. In this position, he was responsible for overseeing vendor quality, ensuring adherence to quality standards, and managing relationships with key vendors.
Employment History at Boston Consulting Group
Nyemba Mbekeani worked at Boston Consulting Group (BCG) for a total of seven years, holding multiple roles. From 2019 to 2022, he served as a Knowledge Expert in Biopharma Operations in Boston, Massachusetts. Prior to this, he was the Lead Knowledge Analyst in Biopharma Operations from 2014 to 2018 in the same location.
Education and Expertise
Nyemba Mbekeani has a diverse educational background. He earned an MBA from Suffolk University and a BS in Chemistry from the University of Illinois Urbana-Champaign. Additionally, he is pursuing a Master's degree in Quantitative Management: Business Analytics from Duke University's Fuqua School of Business (2023-2025). His academic background supports his extensive expertise in biopharma operations.